7MM CKD-HPT, HP, and HK market to get to $4b by 2034
Nevertheless, high anticipated therapy prices might restrict individual accessibility to therapy. The persistent kidney condition (CKD) – hyperparathyroidism (HPT), hyperphosphatemia (HP) and hyperkalemia (HK) market throughout 7 significant markets (7MM) is anticipated